Your browser doesn't support javascript.
loading
Blockade of transforming growth factor-ß signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.
Esaki, Shinichi; Nigim, Fares; Moon, Esther; Luk, Samantha; Kiyokawa, Juri; Curry, William; Cahill, Daniel P; Chi, Andrew S; Iafrate, A John; Martuza, Robert L; Rabkin, Samuel D; Wakimoto, Hiroaki.
Afiliação
  • Esaki S; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Nigim F; Department of Otolaryngology, Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences and Medical School, Nagoya, Japan.
  • Moon E; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Luk S; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Kiyokawa J; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Curry W; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Cahill DP; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Chi AS; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Iafrate AJ; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY.
  • Martuza RL; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Rabkin SD; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Wakimoto H; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Int J Cancer ; 141(11): 2348-2358, 2017 12 01.
Article em En | MEDLINE | ID: mdl-28801914

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Fator de Crescimento Transformador beta / Glioblastoma / Terapia Viral Oncolítica Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Marrocos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Fator de Crescimento Transformador beta / Glioblastoma / Terapia Viral Oncolítica Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Marrocos